๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The immune response to terminal protein of Epstein-Barr virus in nasopharyngeal carcinoma patients

โœ Scribed by T. Afanasyeva; V. Stepina; N. Belousova; T. Kondratyeva; E. Gurtsevitch

Book ID
112781448
Publisher
Springer-Verlag
Year
1995
Tongue
English
Weight
141 KB
Volume
121
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Immune responses to Epsteinโ€“Barr virus l
Immune responses to Epsteinโ€“Barr virus lytic proteins in patients with nasopharyngeal carcinoma
โœ Mei-Ying Liu; Yu-Tzu Huang; Tzung-Shiahn Sheen; Jen-Yang Chen; Ching-Hwa Tsai ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 172 KB

## Abstract Immune responses to three Epsteinโ€“Barr virus (EBV) lytic proteins, DNase, thymidine kinase (TK), and BMRFโ€1 gene products (50/52 kDa diffused early antigen, EAโ€D complex) were determined in EBVโ€infected control individuals and patients with nasopharyngeal carcinoma (NPC). Immunofluoresc

Epstein-Barr virus immune response in hi
Epstein-Barr virus immune response in high-risk nasopharyngeal carcinoma families in Greenland
โœ Jeppe Friborg; Ruth F. Jarrett; Mei-Ying Liu; Kerstin I. Falk; Anders Koch; Ove ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 141 KB

## Abstract Undifferentiated nasopharyngeal carcinoma is associated with Epsteinโ€Barr virus (EBV) infection. Presence of EBV IgA antibodies is rare among healthy individuals and is used as a marker of nasopharyngeal carcinoma in highโ€incidence populations. Reasons for EBV IgA seropositivity are unk